Financial News Feed

Previous Hold Today ANIK ranks #2125 as HOLD CANDIDATE #2125 Next Hold

Anika Therapeutics Inc. stock forecast

ANIK stock forecast

https://www.investing.com/analysis/will-anika-therapeutics-continue-to-surge-higher-200420663...

Read more

The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2019 Q1 earnings call....

Read more

ANIK earnings call for the period ending March 31, 2019....

Read more

No summary available....

Read more

Anika Therapeutics Q1 2019 Earnings Preview
09:35pm, Wednesday, 01'st May 2019
No summary available....

Read more

Anika (ANIK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

Read more

Pune, India, April 17, 2019 (GLOBE NEWSWIRE) -- The global viscouspplementation market size can touch USD 5,243.19 million by 2023, expanding at 8.96% CAGR from 2018 to 2023 (forecast period), as per Market Research Future (MRFR). The ineffectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy have created the high market demand. Large prevalence of OAK is expected to be the major driver of the market. This can be attributed to high obesity rates and physical accidents which led to articular cartilage demand. According to the Center for Disease Control & Prevention (CDC), more than 30 million in the U.S. were diagnosed with osteoarthritis in 2015. Osteoarthritis of the knee (OAK) is a disease becoming highly prevalent among young adults and elder ones as well. Viscosupplementation products combined with hyaluronic acid which can be an effective treatment for providing lubrication and restoring mobility. Launches of novel products are predicted to bode well for the market growth in the forthcoming years....

Read more

Anika Therapeutics Inc. (NASDAQ:ANIK) making news as their share price hit $30.24 at the end of the most recent trading day. Considering that price volatility is equivalent to risk, a commodity’s tr...

Read more

This is a contrast between ChemoCentryx Inc. (NASDAQ:CCXI) and Anika Therapeutics Inc. (NASDAQ:ANIK) based on their analyst recommendations, profitability, risk, dividends, earnings and valuation, ins...

Read more

Mustang Bio Inc. (NASDAQ:MBIO) and Anika Therapeutics Inc. (NASDAQ:ANIK) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, analyst recommendation...

Read more

Anika Therapeutics (ANIK) are in focus as we look at near-term expected movement. The reading from the 40-day commodity channel index is currently Hold. The CCI indicator is mainly used to identify ov...

Read more

Investors sentiment decreased to 0.87 in Q4 2018. Its down 0.28, from 1.15 in 2018Q3. It turned negative, as 16 investors sold Anika Therapeutics, Inc. shares while 55 reduced holdings. 31 funds opene...

Read more

Investors may be tracking technical signals on shares of Anika Therapeutics (ANIK). After a recent check, we have spotted the short-term moving average Hilo channel at Buy. This indicator calculates t...

Read more

In trying to determine the current valuation of UroGen Pharma Ltd. (NasdaqGM:URGN) shares, we note that the Book to Market ratio of the shares stands at 0.119109. It’s commonly accepted that a Book ...

Read more

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank